Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × ruxolitinib × 30 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 5 Thrombocythemia, Essential 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Polycythemia Vera 2 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Leukemia 2 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Graft vs Host Disease 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Rituximab 15 Cyclophosphamide 14 Lenalidomide 12 Prednisone 9 Vincristine 8 Doxorubicin 8 obinutuzumab 5 fludarabine 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 R-CHOP protocol 4 Biopsy 4 Bendamustine Hydrochloride 4 zanubrutinib 3 ibrutinib 3 fludarabine phosphate 3 tisagenlecleucel 2 tazemetostat 2 Whole-Body Irradiation 2 Temozolomide 2 Radiotherapy 2 Prednisolone 2 Oxaliplatin 2 Gemcitabine 2 Cyclosporine 2 CT-P10 2 voruciclib 1 venetoclax 1 umbralisib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡